3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
27
Lung Neoplasms
5
Brain Neoplasms
4
Esophageal Neoplasms
2
EGF-R Positive Non-Small Cell Lung Cancer
2
Adenocarcinoma of Lung
2
Squamous Cell Carcinoma of Lung
1
Plasma EGFR Mutation-positive Lung Cancer
1
Non-small Cell Lung Cancer Metastatic
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Drug-Related Side Effects and Adverse Reactions
1
Bronchial Neoplasms
1
Breast Neoplasms
1
Interventions
durvalumab
3
Carboplatin
3
Radiosurgery
2
Pemetrexed
2
Cisplatin
2
Bevacizumab
2
sotorasib
1
osimertinib
1
icotinib
1
ceralasertib
1
cemiplimab
1
camrelizumab
1
atezolizumab
1
alectinib
1
Toll-Like Receptor 1
1
Technetium Tc 99m Aggregated Albumin
1
Radiotherapy
1
Platinum Compounds
1
Paclitaxel
1
Gemcitabine
1
Etoposide
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Bronchial Neoplasms
×
icotinib
×
Clear all
NCT02264210
2024-09-25
CORIN
Sun Yat-sen University
Phase 2
Completed
128 enrolled
9 charts